Katherine P. Richardson

Nutrition's checkpoint inhibition: The impact of nutrition on immunotherapy outcomes

Jennifer Vaz, Rachael Piver, Bogna Brzezinska, Jessa Suhner et autres

us (code pays fourni par la source)

Multiplex analysis of inflammatory proteins associated with risk of coronary artery disease in type‐1 diabetes patients

C. H. Beatty, Katherine P. Richardson, Paul Tran, Khaled Bin Satter et autres

Abstract Background Chronic uncontrolled hyperglycemia, a precursor to chronic low‐grade inflammation, is a leading cause of coronary artery disease (CAD) due to plaque buildup in type‐1 diabetes (T1D) patients. We evaluated levels of 22 inflammatory markers in cross‐sectional serum samples from 1222 …

us (code pays fourni par la source)

Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma

Chaston Weaver, Khaled Bin Satter, Katherine P. Richardson, Lynn KH Tran et autres

Renal clear cell carcinoma (ccRCC) comprises over 75% of all renal tumors and arises in the epithelial cells of the proximal convoluted tubule. Molecularly ccRCC is characterized by copy number alterations (CNAs) such as the loss of chromosome 3p and VHL inactivation. …

us (code pays fourni par la source)

Development of a Single Molecule Counting Assay to Differentiate Chromophobe Renal Cancer and Oncocytoma in Clinics

Khaled Bin Satter, Zach Ramsey, Paul Tran, Diane Hopkins et autres

Malignant chromophobe renal cancer (chRCC) and benign oncocytoma (RO) are two renal tumor types difficult to differentiate using histology and immunohistochemistry-based methods because of their similarity in appearance. We previously developed a transcriptomics-based classification pipeline with “Chromophobe-Oncocytoma Gene Signature” (COGS) on a …

us (code pays fourni par la source)